Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Higher CRBP1 levels are linked to more severe alopecia areata.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Hair evaluation is crucial for early diagnosis and management of ARCI, as hair loss often indicates severity.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Acinetobacter strain A1-4-2 can safely clean water pollutants.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

AC5 improves hair loss and hair quality with high satisfaction rates.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

CAR is a useful marker for assessing alopecia areata severity.

Upadacitinib improved multiple immune-related conditions in one patient.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

ACA from Alpinia galanga may prevent testosterone-related hair loss.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

Inhibiting ACE2 improves skin regeneration during tissue expansion.

Abatacept may help some people with alopecia areata regrow hair.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.